1-5 of 5
Claire Le Houerou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study

Patrice Chevallier, MD PhD, Sylvain Chantepie, MD, Françoise Huguet, MD, Emmanuel Raffoux, MD PhD, Xavier Thomas, MD PhD, Thibaut Leguay, MD, Tony Marchand, MD, Francoise Isnard, MD PhD, Aude Charbonnier, Sebastien Maury, MD PhD, Maria-Pilar Gallego-Hernanz, MD, Nelly Robillard, PhD, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Fanny Rialland, MD, Claire Le Houerou, David M Goldenberg, ScD, MD, William Wegener, MD PhD, Marie C Bene, Pharm SciD, PhD, Herve Dombret, MD
Journal: Blood
Blood (2016) 128 (22): 4018.
https://doi.org/10.1182/blood.V128.22.4018.4018
Published: 2016
Journal Articles

Chemoimmunotherapy Combining Vincristine, Dexamethasone and Epratuzumab (hLL2) As Salvage Regimen for Older Relapsed/Refractory, CD22 + B-Acute Lymphoblastic Leukemia (B-ALL) Patients: Results of the French Non-Intensive Phase 2 Prospective Cheprall Study

Patrice Chevallier, Françoise Huguet, Emmanuel Raffoux, MD, Anne Etienne, MD, Thibaut Leguay, MD, Françoise Isnard, MD, Nelly Robillard, Thierry Guillaume, MD, Jacques Delaunay, MD, Pierre Peterlin, MD, Aude Charbonnier, MD, Arnaud Pigneux, MD PhD, Claire Le Houerou, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Hervé Dombret, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3710.
https://doi.org/10.1182/blood.V124.21.3710.3710
Published: 2014
Journal Articles

Phase 1 Dose-Escalation Study of 90 yttrium-Labeled Anti-CD22 Epratuzumab Tetraxetan in Adults with Refractory/Relapsed CD22 + B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Patrice Chevallier, MD PhD, Thomas Eugene, MD, Nelly Robillard, Françoise Isnard, MD, Franck E Nicolini, MD PhD, Martine Escoffre-Barbe, MD, Françoise Huguet, Mathilde Hunault, Antoine Marcais, MD, Thierry Guillaume, Jacques Delaunay, MD, Pierre Peterlin, MD, Xavier Thomas, MD PhD, Norbert Ifrah, Simona Lapusan, Caroline bodet-Milin, MD, Alain faivre Chauvet, Claire Le Houerou, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Françoise Kraeber-Bodere, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3708.
https://doi.org/10.1182/blood.V124.21.3708.3708
Published: 2014
Journal Articles

BCR-ABL1 Molecular Remission After 90 y-Epratuzumab Tetraxetan Radioimmunotherapy In CD22 + Ph + B-ALL: A Potential New Treatment Paradigm

Patrice Chevallier, MD, PhD, Caroline bodet-Milin, MD, Nelly Robillard, Thomas Eugene, MD, Audrey Ménard, Claire Le Houerou, Thierry Guillaume, MD, Jacques Delaunay, MD, Martine Escoffre-Barbe, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Françoise kraeber-Bodere, MD
Journal: Blood
Blood (2013) 122 (21): 3910.
https://doi.org/10.1182/blood.V122.21.3910.3910
Published: 2013
Journal Articles

Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults

Marina Illiaquer, PharmD, PhD Student, Berthe-Marie Imbert-Marcille, Pr, Lucie Planche, Marie Rimbert, Claire Le Houerou, Céline Bressollette-Bodin, MD, PhD, Thierry Guillaume, MD, Amandine Le Bourgeois, Jacques Delaunay, MD, Philippe Moreau, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3284.
https://doi.org/10.1182/blood.V122.21.3284.3284
Published: 2013